DP Production Base — Rayhua Zhongshan

Sandoz (China) 's Zhongshan Plant, a DP production base of Sandoz (a division of the Novartis Group) in China, joined Jiuzhou Pharma on March 31, 2023. The site maintains robust quality management systems and provides sophisticated capabilities in solid dosage form and ointment (gel) production, as well as process improvement, technology transfer, and reliable supply.


Floor area:50,000 m2. Existing workshops (China GMP): solid dosage form and ointment (gel); planned workshops: oral solutions, softgels, and anticancer drugs.


Quality management:With robust quality management systems and SOPs, the site obtained certifications/approvals from national, provincial, municipal, and overseas regulatory agencies and passed global quality audits conducted by world-leading pharmaceutical companies.


Management team:The core management team, which hails from world-leading pharmaceutical companies, brings extensive expertise in technology transfer, project management, and quality assurance, as well as experience with China's centralized drug procurement.